3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
108
Lymphoma, Large B-Cell, Diffuse
97
Lymphoma
86
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Lymphoma, Non-Hodgkin
37
Lymphoma, Follicular
37
Burkitt Lymphoma
36
Leukemia
31
Multiple Myeloma
29
Lymphoma, Mantle-Cell
26
Hodgkin Disease
25
Lymphoma, T-Cell, Peripheral
20
Lymphoma, Large-Cell, Immunoblastic
15
Lymphoma, Large-Cell, Anaplastic
15
Lymphoma, B-Cell, Marginal Zone
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Neoplasm Metastasis
13
Lymphoma, B-Cell
13
Leukemia, Lymphocytic, Chronic, B-Cell
12
Recurrence
11
Neoplasms, Plasma Cell
11
Immunoblastic Lymphadenopathy
11
Lymphoma, T-Cell
8
Dendritic Cell Sarcoma, Interdigitating
8
Blast Crisis
8
Neoplasms
7
Enteropathy-Associated T-Cell Lymphoma
7
Waldenstrom Macroglobulinemia
5
Primary Myelofibrosis
5
Myasthenia Gravis
5
Interventions
enzalutamide
4
abiraterone
2
Radiotherapy
2
Metastasectomy
2
Abiraterone Acetate
2
testosterone enanthate
1
pembrolizumab
1
Radium-223
1
Radiosurgery
1
Prednisone
1
Ketoconazole
1
Injections
1
Hydrocortisone
1
Flutamide
1
Crizotinib
1
Control Groups
1
Carboplatin
1
Calcitriol
1
Blood Specimen Collection
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Castration-resistant Prostate Cancer
×
Prednisone
×
Clear all
NCT02429193
2020-01-13
BARRIER-P
University Health Network, Toronto
Phase 2
Completed
16 enrolled